Fetal and subsequent early postnatal iron deficiency causes persistent impairments in cognitive 21 and affective behaviors despite prompt postnatal iron repletion. The long-term cognitive impacts 22 are accompanied by persistent downregulation of brain-derived neurotrophic factor (BDNF), a 23 factor critical for hippocampal plasticity across the life span. This study determined whether 24 early-life iron deficiency epigenetically modifies the Bdnf locus and whether dietary choline 25 supplementation during late gestation reverses these modifications. DNA methylation and 26 histone modifications were assessed at the Bdnf-IV promoter in postnatal day (PND) 65 27 hippocampus of rats that were iron-deficient (ID) during the fetal-neonatal period. Iron 28 deficiency was induced in rat pups by providing pregnant and nursing dams an ID diet (4 mg/kg 29 Fe) from gestational day (G) 2 through PND7, after which iron deficiency was treated with an 30 iron-sufficient (IS) diet (200 mg/kg Fe). This paradigm resulted in about 60% hippocampal iron 31 loss on PND15 with complete recovery by PND65. For choline supplementation, pregnant rat 32 dams were given dietary choline (5 g/kg) from G11 through G18. DNA methylation was 33 determined by quantitative sequencing of bisulfite-treated DNA, revealing a small alteration at 34 the Bdnf-IV promoter. Chromatin immunoprecipitation analysis showed increased HDAC1 35 binding accompanied by reduced binding of RNA polymerase II and USF1 at the Bdnf-IV 36 promoter in formerly ID rats. These changes were correlated with altered histone methylations. 37
grade antibody with an end-over-end rotation (4°C, overnight). The antibody-histone complex 136 was collected by the addition of 50 µL Protein A agarose/Salmon sperm DNA slurry with mixing 137 (4°C, 1 hour). Following washes (per manufacturer's protocol, Millipore), immune-histone 138 complex was eluted in 200 µL of elution buffer (1% SDS, 0.1M NaHCO3). Reverse cross-139 linking was achieved by incubation in NaCl (0.2 M, 65°C, overnight). A protease digestion (20 140 µg proteinase K, 20 mM EDTA, 100 mM Tris-pH6.5, 45°C, 1hour) was performed to recover 141 DNA, which was further purified using ChIP DNA clean and concentration kit (Zymo Research, 142
Irvine, CA). Antibodies used in this study included anti-H4ac (SA Biosciences GAM-0202), 
Real-time PCR 149
For analysis of precipitated DNA from ChIP, SYBR-green PCR (Fast SYBR green master mix, 150 ABI) was used to amplify Bdnf-P4 using the following oligonucleotides: Bdnf-IV forward 151 (GATGAAAGGTTTGGCTTCTGTG) and reverse (TCGGTGAATGGGAAAGTGG) . 152
Oligonucleotides were validated for amplification efficiency (-3.2 slope). These 153 oligonucleotides amplify a 250 bp Bdnf-IV (NW_047673:251697-251947) promoter. Input 154 DNA (10%) was used as a normalizer to account for input amount (ΔCt). Data were expressed 155 as a ratio to IS control (2 -ΔΔCt ) using one of the IS sample as a calibrator (ΔΔCt). For Bdnf 156 mRNA quantitation, Taqman® PCR was used with primers and probes obtained from ABI 157 (Foster City, CA). Real-time PCR was performed with Stratagene 3000P instrument. 158
Western blot analysis 160
To validate the mRNA data, we used Western blot to quantify levels of BDNF protein using a 161 previously described protocol (63). In brief, 30 µg hippocampal protein lysate was separated 162 using a 4-20% SDS-PAGE gel (Novex, Life Technologies). Proteins were blotted onto a 163 nitrocellulose membrane (Pierce, Rockford, IL), blocked with Blocking Buffer for Fluorescent 164
Western blotting (Rockland Inc, Gilbertsville, PA), and incubated with antibodies against BDNF 165 (rabbit IgG, Abcam) and β-actin (mouse monoclonal, Sigma). Following PBS + 0.1% Tween-20 166 washes, blots were incubated in Alexa-700 anti-mouse (Invitrogen, Grand Island, NY) and IR 167
Dye-800 anti-rabbit (Rockland), and analyzed by Near Infrared Fluorescent using Odyssey 168
Infrared Imaging System (Li-Cor Biosciences, Lincoln, NE). Integrated intensity of BDNF 169 normalized to β-actin was determined using Photoshop CS5.1 (Adobe, San Jose, CA). 170
171

Statistics 172
Group differences were analyzed by unpaired t-tests with alpha set at 0.05. Data were graphed 173 and statistically analyzed using Prism 5 GraphPad (GraphPad Software, Inc., San Diego, CA). 174
175
RESULTS: 176
Early-life iron deficiency induces changes in DNA methylation at Bdnf-IV promoter 177
Consistent with our previous findings (4, 62), early-life iron deficiency caused a persistent 178 decrease in hippocampal Bdnf-IV (previous nomenclature BDNF-III) mRNA and BDNF protein 179 hippocampus remains to be determined in future study. We predict that the results are likely 292 affirmative given the evidence of recovered learning behavior and BDNF expression (23). The 293 findings in the present study form a mechanistic basis for the use of dietary choline as an 294 adjunctive therapy to complement iron treatment for early-life iron deficiency. Interestingly,significant reductions in repressive (K27me3) and active (K4me3) marks were detected in the 296 control group supplemented with choline ( Figure 5A , C, ISC group). Additional study is needed 297 to determine whether these changes underlie the reduced Bdnf-IV expression in this group (23). 298
The finding implicates a potential negative impact of too much choline. 299 300
Perspective and Significance 301
Our data provide evidence that early-life iron deficiency remodels chromatin structure to alter 302 Values are mean ± SEM, n = 6-8/group, unpaired t-test, *p<0.05, **p<0.01, and ***p<0.001. 
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